How to Get Patients to Take More Control of Their Medical Decisions
For years, people have been urged be more active in their own care. Now providers are giving them better tools to make that happen. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
GOP Leaders Dare Fellow Republicans to Block Obamacare Repeal
Republican leaders are betting that the only way for Congress to repeal the Affordable Care Act is to set a bill in motion and gamble that fellow GOP lawmakers won ’t dare to block it. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
GOP Governors at Health-Law Impasse
Governors meeting Saturday to discuss health-care policy said they hadn ’t reached a consensus on the future of the Medicaid program, an issue hamstringing Republicans’ bid to alter the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Facing Criticism, Drug Makers Keep Lid On Price Increases
Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President Trump. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 27, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Trump Administration Seeks Delay in Lawsuit Over Health-Law Subsidies
The Trump administration and House Republicans on Tuesday asked a court for a further delay in a lawsuit over certain Affordable Care Act subsidies, a move that may help assuage insurers debating whether to participate in the health law ’s 2018 exchanges. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 22, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Carl Icahn Takes Stake in Bristol-Myers
The same day Bristol-Myers Squibb Co. shook up its board to satisfy one activist investor, the drugmaker was faced with another: Carl Icahn, whose interest is fueling speculation the company could soon be put on the auction block. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 22, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Tyson Seeks Lead in No-Antibiotics Poultry
Tyson Foods Inc. plans to eliminate antibiotics used on poultry in its flagship chicken products, as the largest U.S. meat company mounts a new push to burnish its brands. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 21, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Trump Backing for Bayer's Monsanto Deal Buoys Investors
Investors in Bayer have taken heart from President Donald Trump ’s apparent support for the German pharmaceuticals and chemicals firm’s planned $57 billion takeover of U.S. seed giant Monsanto. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 21, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Antitrust Rulings Put Chill on Health-Insurance Mergers
Cigna called off the roughly $48 billion merger with Anthem and filed a lawsuit against its suitor, the second such health-insurer deal to fall apart. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Door Opens to Gene Editing in Embryos
The nonprofit National Academies of Sciences and the National Academy of Medicine commissioned a study of the ethical, scientific and regulatory questions raised by editing genes in sperm, eggs and early-stage embryos. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 15, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Merck Stops Clinical Trial of Alzheimer's Drug
Merck& Co. said Tuesday it stopped a clinical trial of an experimental Alzheimer ’s drug because it wasn’t helping patients. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Teva Swings to Loss, But Beats Expectations
Teva Pharmaceuticals swung to a loss on an acquisition write-down, as its interim CEO contends with a deal-driven debt load, though shares rose as the company beat revenue and profit expectations. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
No Drugs for Back Pain, New Guidelines Say
The American College of Physicians says back pain of all kinds should be treated with natural and alternative therapies, such as exercise, acupuncture and mindfulness. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Firm Delays Muscular Dystrophy Drug Launch Amid Criticism of $89,000 Price
Marathon Pharmaceuticals will delay the U.S. launch of its muscular dystrophy drug amid mounting criticism of its $89,000-a-year price, including from two members of Congress who launched an investigation Monday. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 14, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
The Rise and Fall of a K Street Renegade
Evan Morris, a high-flying corporate lobbyist, is suspected by federal prosecutors of embezzling millions of dollars from his employers, Roche and then Genentech. The probe is shaping up to be one of the biggest Washington influence scandals in years. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 13, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
